Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

The recent surge in multidrug-resistant pathogens combined with the diminishing antibiotic pipeline has created a growing need to optimize the use of our existing antibiotic armamentarium, particularly in the management of intensive care unit (ICU) patients. Optimal and timely pharmacokinetic/pha...

Full description

Bibliographic Details
Main Authors: Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Mouton, Johan W., Hope, William W., Roberts, Jason A.
Format: Article
Language:English
Published: Thieme Medical Publishers 2015
Subjects:
Online Access:http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/1/s-0034-1398490.pdf
id iium-41237
recordtype eprints
spelling iium-412372016-11-11T08:29:46Z http://irep.iium.edu.my/41237/ Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development Abdul Aziz, Mohd. Hafiz Lipman, Jeffrey Mouton, Johan W. Hope, William W. Roberts, Jason A. RM Therapeutics. Pharmacology RS Pharmacy and materia medica The recent surge in multidrug-resistant pathogens combined with the diminishing antibiotic pipeline has created a growing need to optimize the use of our existing antibiotic armamentarium, particularly in the management of intensive care unit (ICU) patients. Optimal and timely pharmacokinetic/pharmacodynamic (PK/PD) target attainment has been associated with an increased likelihood of clinical andmicrobiological success in critically ill patients. Emerging data, mostly from in vitro and in vivo studies, suggest that optimization of antibiotic therapy should not only aim to maximize clinical outcomes but also to include the suppression of resistance. The development of antibiotic dosing regimens that adheres to the PK/PD principles may prolong the clinical lifespan of our existing antibiotics by minimizing the emergence of resistance. This article summarizes the relevance of PK/PD characteristics of different antibiotic classes on the development of antibiotic resistance. On the basis of the available data, we propose dosing recommendations that can be adopted in the clinical setting, to maximize therapeutic success and limit the emergence of resistance in the ICU. Thieme Medical Publishers 2015-02 Article PeerReviewed application/pdf en http://irep.iium.edu.my/41237/1/s-0034-1398490.pdf Abdul Aziz, Mohd. Hafiz and Lipman, Jeffrey and Mouton, Johan W. and Hope, William W. and Roberts, Jason A. (2015) Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. Seminars in Respiratory and Critical Care Medicine, 36 (1). pp. 136-153. ISSN 1069-3424. http://www.thieme.com/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=915&category_id=90&option=com_virtuemart&Itemid=53 http://dx.doi.org/ 10.1055/s-0034-1398490
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RM Therapeutics. Pharmacology
RS Pharmacy and materia medica
spellingShingle RM Therapeutics. Pharmacology
RS Pharmacy and materia medica
Abdul Aziz, Mohd. Hafiz
Lipman, Jeffrey
Mouton, Johan W.
Hope, William W.
Roberts, Jason A.
Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
description The recent surge in multidrug-resistant pathogens combined with the diminishing antibiotic pipeline has created a growing need to optimize the use of our existing antibiotic armamentarium, particularly in the management of intensive care unit (ICU) patients. Optimal and timely pharmacokinetic/pharmacodynamic (PK/PD) target attainment has been associated with an increased likelihood of clinical andmicrobiological success in critically ill patients. Emerging data, mostly from in vitro and in vivo studies, suggest that optimization of antibiotic therapy should not only aim to maximize clinical outcomes but also to include the suppression of resistance. The development of antibiotic dosing regimens that adheres to the PK/PD principles may prolong the clinical lifespan of our existing antibiotics by minimizing the emergence of resistance. This article summarizes the relevance of PK/PD characteristics of different antibiotic classes on the development of antibiotic resistance. On the basis of the available data, we propose dosing recommendations that can be adopted in the clinical setting, to maximize therapeutic success and limit the emergence of resistance in the ICU.
format Article
author Abdul Aziz, Mohd. Hafiz
Lipman, Jeffrey
Mouton, Johan W.
Hope, William W.
Roberts, Jason A.
author_facet Abdul Aziz, Mohd. Hafiz
Lipman, Jeffrey
Mouton, Johan W.
Hope, William W.
Roberts, Jason A.
author_sort Abdul Aziz, Mohd. Hafiz
title Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
title_short Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
title_full Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
title_fullStr Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
title_full_unstemmed Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
title_sort applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
publisher Thieme Medical Publishers
publishDate 2015
url http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/
http://irep.iium.edu.my/41237/1/s-0034-1398490.pdf
first_indexed 2023-09-18T20:59:04Z
last_indexed 2023-09-18T20:59:04Z
_version_ 1777410500832788480